Representative Don Bacon Co-Sponsors PKD Cures Act to Advance Polycystic Kidney Disease Research
Representative Don Bacon (R-Neb.) has co-sponsored the PKD Cures Act, bipartisan legislation introduced in the U.S. House of Representatives aimed at advancing research for polycystic kidney disease (PKD). This bill, also co-sponsored by Reps. Debbie Wasserman Schultz (D-Fla.), Carol Miller (R-W.Va.), and Emanuel Cleaver (D-Mo.), marks the first federal legislation exclusively dedicated to PKD research. The PKD Cures Act seeks to expand research initiatives at the National Institutes of Health, accelerate clinical trials and the development of new therapies, establish research priorities through expert and patient input, and create a long-term federal research roadmap. The PKD Foundation is actively advocating for the bill's passage, coinciding with PKD Awareness Day, to capitalize on the current rapid pace of PKD research and ensure that scientific discoveries translate into patient treatments more quickly. Approximately 500,000 people in the U.S. live with PKD, a genetic disorder that can lead to kidney ...